IFF vs TCRX · P/E 24, rev $3.86B vs rev $2.0M
International Flavors & Fragrances Inc (IFF) versus Tscan Therapeutics Inc (TCRX) — a side-by-side from cached financials, not a winner call.
International Flavors & Fragrances Inc (IFF) is a specialty chemicals company listed on NYSE.
Tscan Therapeutics Inc (TCRX) is a biotechnology company listed on NASDAQ.
Latest reported IFF revenue for 2026-06-30 was $3.86B. Net income was $219.0M. Revenue was up 40.8% from 2026-03-31 to 2026-06-30. IFF currently screens at market cap $19.42B and trailing P/E 23.5.
Latest reported TCRX revenue for 2026-06-30 was $2.0M. Net income was -$59.0M. TCRX currently screens at market cap $62.1M.
IFF currently screens at market cap $19.42B and trailing P/E 23.5. TCRX currently screens at market cap $62.1M.
Not investment advice. Open the IFF and TCRX stock pages for the full models.
Not investment advice.